Advanced Cell Technology Invited to Deliver Keynote Address at Prestigious International Stem Cell Therapy and Regenerative Medicine Conference in London CEO William Caldwell to Discuss ACTC’s Strategies for Development and Commercialization of Novel Stem Cell-Based Medical Treatments
ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology (ACTC), Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, announced today that William Caldwell IV, Chairman and Chief Executive Officer, has been invited to present an overview of the Company’s proprietary stem cell science and therapeutic programs at the upcoming 4th Annual Commercialization of Tissue Engineering and Cell Therapy, to be held December 14 and 15, 2006, in London.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.